benmelstobart combined with chemotherapy

DRUG2 trials

Sponsors

Xinqiao Hospital of Chongqing, Tang-Du Hospital

Conditions

Limited Stage Small Cell Lung CancerNSCLC Stage IV Without EGFR/ALK Mutation

Phase 2

Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases

RecruitingNCT06953843

Xinqiao Hospital of ChongqingNSCLC Stage IV Without EGFR/ALK Mutation

Start: 2025-07-09End: 2027-12-31Target: 366Updated: 2025-07-14

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Not yet recruitingNCT06978153

Tang-Du HospitalLimited Stage Small Cell Lung Cancer

Start: 2025-05-20End: 2027-11-01Target: 66Updated: 2025-05-18